Fasikl, Inc.
PrivateLast Round
Series B
Sep 10, 2025
Total Funding Raised
$59.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fasikl, Inc. is a neuro-AI company that develops cloud-connected, AI-powered neuromodulation technologies and therapeutics for movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotechnology
Business Model
B2B2C
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fasikl, Inc. Comparables
Compare Fasikl, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encora Therapeutics | 87% | |
| Allevion Therapeutics | 85% | |
| Cala Health | 85% | |
Fasikl, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 10, 2025 | ||||
| Series A Extension | Sep 10, 2024 | ||||
| Series A | Mar 3, 2023 | ||||
| Seed | Nov 1, 2021 |
Key People
Founding team and executive leadership
Fasikl, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iSeed | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 122% MoM, reaching 4.1K.
- May 2, 2026
Flagship non-invasive neuromodulation solution for essential tremor is FDA-cleared.
Fasikl, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fasikl, Inc.'s valuation, stock price, and market status.